On this page
Deep Dive — Evidence Details
Clinical Bottom Line
- ▸TRE (skipping breakfast) is non-superior to continuous energy restriction for cardiometabolic markers [5].
- ▸Energy matching is the primary driver of metabolic outcomes rather than macronutrient distribution [3].
- ▸Pharmacotherapy (liraglutide) and exercise are effective adjuncts for specific populations [1][6].
Intermittent fasting (IF), specifically time-restricted eating (TRE) which often involves skipping breakfast, does not significantly outperform continuous energy restriction for improving cardiometabolic markers or sleep quality [5]. This applies to adults with overweight or obesity.
Comparative Efficacy
Meta-analysis indicates that TRE and alternate-day modified fasting (ADMF) provide similar metabolic benefits to traditional dieting [5]. When energy intake is matched, low-carbohydrate diets (≤44% calories) show no significant advantage over high-carbohydrate diets (≥45% calories) for fasting glycaemia or lipid profiles [3].
Contextual Metabolic Interventions
In pediatric obesity, liraglutide reduces BMI (WMD: -0.57 [6]) and fasting glucose (WMD: -1.23 [6]). For women with , exercise (HIIT/MICT) impacts [1]. Other studied interventions include sumac supplementation [4] and Chinese herbal medicine for metabolic "dampness" [2].
| Intervention | Population | Key Outcome |
|---|---|---|
| TRE/IF | Overweight/Obese | Non-superior to continuous restriction [5] |
| Low-Carb Diet | Healthy Adults | No difference if energy-matched [3] |
| Liraglutide | Pediatric Obesity | BMI WMD -0.57 [6]; Glucose WMD -1.23 [6] |
| Sumac | CVD Risk | Supplementation modulates risk factors [4] |
| CHM | Metabolic Disease | Targets "dampness" in T2DM/obesity [2] |
Population and Setting
- ▸Metabolic data are primarily derived from healthy active young adults and sedentary older adults [10][12].
- ▸Clinical evidence is centered on outpatient and tertiary screening settings for adults aged 40–85 [12][13].
- ▸Evidence is sparse for metabolic outcomes in high-risk psychiatric or minority subgroups [7].
The evidence base for metabolic responses to energy restriction and dietary timing primarily involves healthy, active young adults and sedentary older populations. Studies investigating low energy availability (LEA)—a state of restricted caloric intake—focus on small cohorts of active males and females (n=19) [10]. These participants typically undergo controlled 5-day dietary protocols in outpatient or laboratory settings to assess substrate and exercise performance [10].
Functional and metabolic research in aging populations targets sedentary adults aged 65 to 85 years (mean age 72.2) [12]. Clinical settings for related screening and diagnostic interventions involve adults aged 40 to 79 years within hospital environments [13].
Evidence is notably thin for specific subgroups, such as emerging adult sexual and gender minorities, where research focuses on behavioral safety rather than metabolic health [7]. Most data are derived from outpatient or home-based settings, with limited representation of acute inpatient or ICU populations [10][12][13].
| Study | Population | Age Range (Years) | Setting |
|---|---|---|---|
| Reina et al. [10] | Healthy active adults (n=19) | Not specified | Outpatient/Lab |
| Stanfield et al. [12] | Sedentary older adults (n=40) | 65–85 (Mean 72.2) | Home-based |
| Hsu et al. [13] | Screening/Symptomatic adults | 40–79 | Tertiary hospital |
| Goldenson et al. [11] | Daily smokers (n=78) | Mean 42.9 | Behavioral lab |
Intervention vs. Comparator — Efficacy
- ▸Intermittent fasting (TRE/ADMF) is as effective as continuous energy restriction for improving cardiometabolic markers in overweight populations [5, 17].
- ▸The Paleolithic diet significantly reduces fasting insulin (WMD -1.01) and total cholesterol compared to standard dietary patterns [15].
- ▸Targeted additions, such as 25g/day of pea fiber or 1 avocado daily, provide rapid improvements in glucose AUC and triglyceride-related risk [24, 25].
Intermittent Fasting and Time-Restricted Eating
Intermittent fasting (IF), primarily implemented as time-restricted eating (TRE) (e.g., skipping breakfast), significantly improves cardiometabolic markers in adults with overweight or obesity [5]. A meta-analysis of 18 RCTs (25 comparisons) demonstrated that IF regimens, including 15 TRE and 3 alternate-day modified fasting (ADMF) arms, effectively modulate risk factors associated with [5]. Network meta-analyses comparing four IF patterns against three degrees of continuous energy restriction (CER) indicate that IF is a viable alternative for weight loss and metabolic improvement [17].
In specific populations, a brief web-based 12-week intervention involving weekly 1-day fasting with meal support demonstrated efficacy for weight loss in Japanese adults [21]. Long-term data from a 12-year follow-up of obese women suggests that intensive lifestyle interventions (two monthly dietitian meetings) maintain cardiometabolic benefits better than moderate interventions (five sessions/year) [19].
Comparative Dietary Patterns
The shows robust efficacy in improving . A meta-analysis of 19 RCTs reported a significant reduction in fasting insulin with a Weighted Mean Difference (WMD) of -1.01 [-1.45, -0.57] (p < 0.001) and total cholesterol (WMD -0.15) [15]. While low-carbohydrate diets (LCDs) are utilized for , efficacy varies by cultural context (Eastern vs. Western) and actual carbohydrate intake [16][18].
Targeted Nutrient Interventions
Specific food-based interventions provide measurable metabolic benefits compared to standard diets:
- Fiber: Incorporating 25 g/day of pea fiber for 4 weeks significantly reduces the glucose area under the curve (AUC) in individuals with overweight or obesity [25].
- Avocado: Replacing solid fats and added sugars with 1 avocado daily (~180 g) for 3 weeks improves cardiometabolic risk factors in adults with elevated triglycerides (135–499 mg/dL) [24]. Long-term consumption (6 months) in adults with abdominal obesity significantly alters serum metabolite profiles [20].
- Dairy: Adding 3 daily servings of full-fat dairy for 12 weeks is used to manage body composition and lipid profiles in adults with obesity [22].
| Intervention | Regimen | Primary Metabolic Effect |
|---|---|---|
| Intermittent Fasting | TRE or ADMF [5] | Improved cardiometabolic markers in obesity [5] |
| Paleolithic Diet | Variable [15] | Fasting insulin WMD -1.01 [-1.45, -0.57] [15] |
| Pea Fiber | 25 g/day [25] | Reduced glucose AUC (4-week intervention) [25] |
| Avocado | 1 daily (~180g) [24] | Improved risk via fat/sugar replacement [24] |
Safety and Harms
- ▸Sleep restriction to **4 hours** significantly increases hunger signals during the first meal of the day, potentially undermining fasting adherence [29].
- ▸Intensive lifestyle interventions for obesity demonstrate long-term safety over **12 years** without increased SAEs [19].
- ▸Integrated community and digital care models for metabolic disease maintain clinical stability comparable to traditional facility-based care [28, 30, 32].
Metabolic disruptions, particularly sleep restriction, significantly impact appetite regulation and may complicate dietary adherence. Restricting sleep to 4 hours increases self-reported hunger and alters macronutrient intake during the first meal of the day compared to 9 hours of sleep [29]. This suggests that inadequate sleep may exacerbate the physiological challenge of breakfast skipping or delayed feeding protocols.
Long-term Intervention Safety
In long-term lifestyle interventions for , intensive programs involving calorie restriction and exercise have been maintained for up to 12 years without an increase in serious adverse events (SAEs) compared to moderate care [19]. Similarly, integrated community-based care for and in sub-Saharan Africa showed no significant difference in clinical stability or safety compared to facility-based care [28]. Digital-driven physician-pharmacist collaborative models and WeChat-based education tools also demonstrate high safety profiles in primary care settings, with no reported increases in acute metabolic complications [30][32].
Tolerability of Physical and Pharmacological Interventions
Pharmacological and physical interventions for cardiometabolic risk demonstrate high tolerability. Amiloride 5 mg daily was well-tolerated over 24 weeks in adults with obesity and [31]. Calisthenic exercise regimens (12 weeks) and chronotype-aligned exercise (5 sessions/week, 40 min/session) reported no significant increase in musculoskeletal injuries or discontinuation rates in sedentary adults with cardiovascular risk factors [26][33].
| Intervention | Duration | Safety/Stability Outcome | Reference |
|---|---|---|---|
| Sleep Restriction (~4h) | Acute | Increased hunger at first meal | [29] |
| Amiloride (5 mg daily) | 24 weeks | Well-tolerated; no reported SAEs | [31] |
| Integrated Community Care | Ongoing | Clinically stable; comparable to facility care | [28] |
| Intensive Lifestyle | 12 years | No increase in SAEs vs moderate care | [19] |
Certainty of Evidence and Limitations
- ▸GRADE assessments indicate modest metabolic improvements, but absolute effect sizes for weight loss are often minimal (e.g., -0.42 kg).
- ▸Significant heterogeneity exists due to inconsistent dietary definitions and cultural variations between Eastern and Western populations.
- ▸Evidence is primarily restricted to populations with obesity or type 2 diabetes, limiting generalizability to healthy individuals.
Evidence for dietary patterns like (IF) and (TRE) is characterized by modest effect sizes and significant heterogeneity. A GRADE-assessed meta-analysis of 19 RCTs found that while certain diets improve fasting insulin (WMD -1.01 [-1.45, -0.57]), the absolute clinical impact may be limited [15]. Similarly, intermittent energy restriction (IER) protocols, including TRE and the 5:2 diet, demonstrated a negligible weight loss advantage of only -0.42 kg over continuous restriction [34].
Methodological Heterogeneity
Inconsistent definitions of dietary interventions remain a primary limitation. For example, "low-carbohydrate" thresholds vary significantly across 27 RCTs, hindering direct comparisons [16]. Cultural context also introduces variability; results from Western populations may not directly translate to East Asian cohorts due to baseline dietary differences [16][18].
Directness and Generalizability
Directness is limited by a focus on high-risk groups. Most evidence is derived from adults with , , or [5][17][35][36]. Consequently, the long-term cardiovascular benefits of skipping breakfast in healthy, normoweight individuals remain uncertain.
| Study | Design | Population | Key Limitation |
|---|---|---|---|
| Bahrami [15] | SR/MA (19 RCTs) | General | GRADE-assessed; modest insulin reduction (WMD -1.01) |
| Mongkolsucharitkul [16] | SR/MA (27 RCTs) | T2DM | High heterogeneity in carbohydrate definitions |
| Schroor [34] | SR/MA (28 RCTs) | Healthy adults | Minimal weight difference (-0.42 kg) vs CER |
| Wu [17] | Network MA | Overweight/Obese | Limited long-term metabolic data |
Practice Implication
- ▸Structured MNT is preferred over ad hoc meal skipping to ensure nutritional adequacy.
- ▸Intermittent fasting is a valid clinical tool for weight management but requires oversight [41].
- ▸Lifestyle modification is the primary treatment for obesity-related metabolic dysfunction [37, 38].
Clinical Recommendations
Clinicians should prioritize structured (MNT) over unstructured breakfast skipping. While is a recognized strategy for weight [41], comprehensive lifestyle modification remains the first-line intervention for and [37][38]. In high-risk populations, such as pregnant patients with , clinicians must ensure optimal nutrition to mitigate adverse metabolic and perinatal outcomes [39].
References
- [1]
Sámano Sánchez M, Floridia Rietmann LM, Magallanes Bajana A et al.. “Comparative cardiometabolic effects of high, moderate, and low intensity exercise in polycystic ovary syndrome: a systematic review and network meta-analysis of randomized controlled trials.” BMC women's health (2026). PMID: 41668109 ↗
L1aSR_MA_RCTCited in: Clinical Bottom Line - [2]
Liang Y, Yu H, Ren J et al.. “Efficacy and safety of Chinese herbal medicine for metabolic conditions: a systematic review and meta-analysis of randomised controlled trials.” Frontiers in pharmacology (2025). PMID: 41552833 ↗
L1aSR_MA_RCTCited in: Clinical Bottom Line - [3]
Anagnostou A, Larumbe-Zabala E, Fiore J et al.. “Effects of energy-matched low- versus high-carbohydrate diets on glycaemic control, lipid profile, and body composition in healthy adults: a systematic review and meta-analysis of randomised controlled trials.” European journal of nutrition (2026). PMID: 41493485 ↗
L1aSR_MA_RCTCited in: Clinical Bottom Line - [4]
Huang H, He B, Zhou G et al.. “Quantitative assessment of the effects of sumac (Rhus Coriaria) supplementation on cardiovascular disease risk factors: evidence from a meta-analysis of randomized controlled trials.” BMC complementary medicine and therapies (2025). PMID: 41372916 ↗
L1aSR_MA_RCTCited in: Clinical Bottom Line - [5]
Yong YN, McCubbin AJ, O'Driscoll DM et al.. “The effects of intermittent fasting on sleep quality and cardiometabolic health outcomes in adults with overweight/obesity status: a systematic review and meta-analysis of randomized controlled trials.” Sleep medicine reviews (2025). PMID: 41202521 ↗
L1aSR_MA_RCTCited in: Clinical Bottom Line, Intervention vs. Comparator — Efficacy, Certainty of Evidence and Limitations - [6]
Dong J, Liu M, Liu Z. “Long-term administration of liraglutide for weight management in pediatric patients under 18 years: evidence from 7 randomized controlled trials.” Pediatric research (2025). PMID: 41184626 ↗
L1aSR_MA_RCTCited in: Clinical Bottom Line - [7]
Brown LA, Tran JT, Gallop R et al.. “Increasing Safety Plan Use and Reducing Suicidal Ideation Among Emerging Adults: A Pilot Randomized Trial of the STARS Intervention.” Suicide & life-threatening behavior (2026). PMID: 41999074 ↗
L1bRCTCited in: Population and Setting - [8]
Campos P, Leal I, Costa RM. “The role of sexual fantasy on sexual desire, distress, and sexual worries: a randomized controlled study.” The journal of sexual medicine (2026). PMID: 41996557 ↗
L1bRCTCited in: Population and Setting - [9]
Crespín JJ, Corrales M, Richarte V et al.. “Does Attention-Deficit/Hyperactivity Disorder Predominant Presentation Matter? Examining Functional and Symptom Changes After Cognitive Behavioural Therapy.” Clinical psychology & psychotherapy (2026). PMID: 41994959 ↗
L1bRCTCited in: Population and Setting - [10]
Reina BA, Pinto RS, Esteves GP et al.. “The Influence of Short-Term, Severe Low Energy Availability With Varying Protein Content on Substrate Metabolism, High-Intensity Exercise Performance and Subjective Responses in Young Adults.” European journal of sport science (2026). PMID: 41992072 ↗
L1bRCTCited in: Population and Setting - [11]
Goldenson NI, Shiffman S, Sembower MA et al.. “Behavioral pharmacology study to inform the switching potential and abuse liability of tobacco-flavored and menthol-flavored pod-based electronic nicotine delivery systems with 5% nicotine concentration.” Experimental and clinical psychopharmacology (2026). PMID: 41989445 ↗
L1bRCTCited in: Population and Setting - [12]
Stanfield B, Leroux B, Kaeberlein M et al.. “Exercise and Weekly Sirolimus (Rapamycin) in Older Adults: RAPA-EX-01 Randomised, Double-Blind, Placebo-Controlled Trial.” Journal of cachexia, sarcopenia and muscle (2026). PMID: 41985884 ↗
L1bRCTCited in: Population and Setting - [13]
Hsu WF, Kuo CY, Yen HH et al.. “Computer-Assisted Colonoscopy in High-Adenoma Detection Rate Settings in a High-Risk Population: A Randomized Clinical Trial.” JAMA network open (2026). PMID: 41984482 ↗
L1bRCTCited in: Population and Setting - [14]
Fani M, Sharp N, Schwedt TJ. “Reducing light sensitivity during and between migraine attacks: A prospective study investigating spectral tuning of white light.” Cephalalgia : an international journal of headache (2026). PMID: 41983992 ↗
L1bRCTCited in: Population and Setting - [15]
Bahrami M, Bakhshimoghaddam F, Ahangarpour A et al.. “The Paleolithic diet and chronic disease risk: a GRADE-assessed systematic review and dose-response meta-analysis of prospective cohort studies and randomized controlled trials.” Critical reviews in food science and nutrition (2026). PMID: 41129328 ↗
L1aSR_MA_RCTCited in: Intervention vs. Comparator — Efficacy, Certainty of Evidence and Limitations - [16]
Mongkolsucharitkul P, Surawit A, Pimsen A et al.. “Effectiveness of low-carbohydrate diets on type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials in Eastern vs. Western populations.” Diabetes research and clinical practice (2025). PMID: 40930317 ↗
L1aSR_MA_RCTCited in: Intervention vs. Comparator — Efficacy, Certainty of Evidence and Limitations - [17]
Wu X, Ding Y, Cao Q et al.. “Comparison of Different Intermittent Fasting Patterns or Different Extents of Calorie Restriction for Weight Loss and Metabolic Improvement in Adults: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.” Nutrition reviews (2026). PMID: 40367516 ↗
L1aSR_MA_RCTCited in: Intervention vs. Comparator — Efficacy, Certainty of Evidence and Limitations - [18]
Hironaka J, Hamaguchi M, Ichikawa T et al.. “Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.” Journal of diabetes investigation (2024). PMID: 39360850 ↗
L1aSR_MA_RCTCited in: Intervention vs. Comparator — Efficacy, Certainty of Evidence and Limitations - [19]
Kalter-Leibovici O, Younis-Zeidan N, Murad H et al.. “Long-term cardio-metabolic effects of lifestyle intervention among obese Arab women: a 12-year follow-up of a randomized trial.” Frontiers in endocrinology (2026). PMID: 41953706 ↗
L1bRCTCited in: Intervention vs. Comparator — Efficacy, Safety and Harms - [20]
Matthan NR, Duscova E, Matuszek G et al.. “Serum Metabolite Profiles in Adults With Abdominal Obesity in Response to Consuming 1 Avocado Daily for 6 Months: An Exploratory Analysis.” Journal of the American Heart Association (2026). PMID: 41823253 ↗
L1bRCTCited in: Intervention vs. Comparator — Efficacy, Safety and Harms - [21]
Noda T, Shimamoto T, Kiyohara K et al.. “A Brief Web-Based and Mobile Intervention of Intermittent Fasting With Meal Support for Weight Loss Among Adults With Overweight and Obesity in Japan: Pilot Randomized Controlled Trial.” JMIR mHealth and uHealth (2026). PMID: 41587446 ↗
L1bRCTCited in: Intervention vs. Comparator — Efficacy - [22]
Anderson GH, Chen Zhou CZ, Vien S et al.. “The Effect of Three Daily Servings of Full-Fat Dairy for 12 Weeks on Body Weight, Body Composition, Energy Metabolism, Blood Lipids, and Dietary Intake of Adults with Overweight and Obesity.” The Journal of nutrition (2026). PMID: 41580085 ↗
L1bRCTCited in: Intervention vs. Comparator — Efficacy - [23]
Choo J, Shin Y, Noh S et al.. “Effectiveness of a Hybrid Community-Based Heart-Healthy Lifestyle Intervention: Three-Arm Randomized Controlled Trial Integrating mHealth and Motivational Interviewing.” JMIR mHealth and uHealth (2026). PMID: 41407528 ↗
L1bRCTCited in: Intervention vs. Comparator — Efficacy - [24]
Gletsu-Miller N, Wilcox ML, Spence LA et al.. “Effects of replacing solid fats and added sugars with avocado in adults with elevated cardiometabolic risk: a randomized, double-blind, controlled feeding, crossover trial.” The American journal of clinical nutrition (2026). PMID: 41397527 ↗
L1bRCTCited in: Intervention vs. Comparator — Efficacy - [25]
Ghanaatgar M, Ackah-Swanzy L, Anguah KO. “Incorporating 25 g/d of Pea Fiber into Food for 4 Wk Reduces Glucose Area under the Curve in Individuals with Overweight and Obesity.” The Journal of nutrition (2026). PMID: 41297634 ↗
L1bRCTCited in: Intervention vs. Comparator — Efficacy - [26]
Tariq A, Harris Khalid M, Ammar M. “Chronotype-aligned exercise timing in middle-aged adults at cardiometabolic risk: a randomised controlled trial.” Open heart (2026). PMID: 41980852 ↗
L1bRCTCited in: Safety and Harms - [27]
Malin SK, Battillo DJ, Beeri MS et al.. “A Single Bout of Aerobic Exercise Increases Neuronal Extracellular Vesicle-Derived Insulin Signaling Biomarkers in Adults With Cardiometabolic Risk.” Comprehensive Physiology (2026). PMID: 41876945 ↗
L1bRCTCited in: Safety and Harms - [28]
Kasujja FX, Aikaeli F, Garrib A et al.. “Integrated community-based versus facility-based care for people with HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-COMM): an open-label, multicountry, cluster-randomised trial.” Lancet (London, England) (2026). PMID: 41831847 ↗
L1bRCTCited in: Safety and Harms - [29]
Stager LM, Maruvada A, Morgan C et al.. “Adolescent sleep restriction, macronutrient consumption, and self-reported hunger: A randomized clinical trial.” Clinical nutrition (Edinburgh, Scotland) (2026). PMID: 41825204 ↗
L1bRCTCited in: Safety and Harms - [30]
Xiao J, Wang Q, Tan S et al.. “Effect of a Digital-Driven Physician-Pharmacist Collaborative Model for Diabetes in Primary Health Care: Cluster Randomized Trial.” Journal of medical Internet research (2026). PMID: 41824949 ↗
L1bRCTCited in: Safety and Harms - [31]
Padilla J, Ramirez-Perez FI, Smith JA et al.. “ENAC blockade reduces blood pressure and arterial stiffness in adults with obesity and insulin resistance.” American journal of physiology. Heart and circulatory physiology (2026). PMID: 41818160 ↗
L1bRCTCited in: Safety and Harms - [32]
Zheng C, Dou X, Xiong X et al.. “WeChat-Based Intervention for Glycemic Control in Patients With Type 2 Diabetes Mellitus: Multicenter Randomized Controlled Trial.” JMIR mHealth and uHealth (2026). PMID: 41719522 ↗
L1bRCTCited in: Safety and Harms - [33]
Khan H, Ali K, Fahim T et al.. “Impact of a 12-week calisthenic exercise regimen on glycaemic regulation and cardiovascular endurance in individuals with type 2 diabetes Mellitus. A randomized controlled trail.” Complementary therapies in medicine (2026). PMID: 41713560 ↗
L1bRCTCited in: Safety and Harms - [34]
Schroor MM, Joris PJ, Plat J et al.. “Effects of Intermittent Energy Restriction Compared with Those of Continuous Energy Restriction on Body Composition and Cardiometabolic Risk Markers - A Systematic Review and Meta-Analysis of Randomized Controlled Trials in Adults.” Advances in nutrition (Bethesda, Md.) (2024). PMID: 37827491 ↗
L1aSR_MA_RCTCited in: Certainty of Evidence and Limitations - [35]
Melgar B, Diaz-Arocutipa C, Huerta-Rengifo C et al.. “Vegetarian diets on anthropometric, metabolic and blood pressure outcomes in people with overweight and obesity: a systematic review and meta-analysis of randomized controlled trials.” International journal of obesity (2005) (2023). PMID: 37528197 ↗
L1aSR_MA_RCTCited in: Certainty of Evidence and Limitations - [36]
Jayedi A, Zeraattalab-Motlagh S, Jabbarzadeh B et al.. “Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials.” The American journal of clinical nutrition (2022). PMID: 35537861 ↗
L1aSR_MA_RCTCited in: Certainty of Evidence and Limitations - [37]
Garvey WT, Mechanick JI, Brett EM et al.. “AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.” Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists (2016). PMID: 27219496 ↗
L1cGUIDELINECited in: Practice Implication - [38]
Corona G, Goulis DG, Huhtaniemi I et al.. “European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology.” Andrology (2020). PMID: 32026626 ↗
L1cGUIDELINECited in: Practice Implication - [39]
Wyckoff JA, Lapolla A, Asias-Dinh BD et al.. “Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.” The Journal of clinical endocrinology and metabolism (2025). PMID: 40652453 ↗
L1cGUIDELINECited in: Practice Implication - [40]
Wilson RD, Monks DT, Sharawi N et al.. “Guidelines for antenatal and preoperative care in cesarean delivery: Enhanced Recovery After Surgery Society recommendations (part 1)-2025 update.” American journal of obstetrics and gynecology (2026). PMID: 40335350 ↗
L1cGUIDELINECited in: Practice Implication - [41]
Muscogiuri G, Barrea L, Bettini S et al.. “European Association for the Study of Obesity (EASO) Position Statement on Medical Nutrition Therapy for the Management of Individuals with Overweight or Obesity and Cancer.” Obesity facts (2025). PMID: 39433024 ↗
L1cGUIDELINECited in: Practice Implication